Quest for the right Drug

|
עמוד הבית / פק-מרץ טבליות / מידע מעלון לרופא

פק-מרץ טבליות PK-MERZ TABS (AMANTADINE SULFATE)

תרופה במרשם תרופה בסל נרקוטיקה ציטוטוקסיקה

צורת מתן:

פומי : PER OS

צורת מינון:

טבליות מצופות פילם : FILM COATED TABLETS

Overdose : מינון יתר

4.9     Overdose
Emergency measures, symptoms and antidotes

The possibility of multiple intoxication must always be considered, for example ingestion of more than one drug with suicidal intention.
a) Symptoms of overdose
Acute intoxication is characterised by nausea, vomiting, hyperexcitability, tremor, ataxia, blurred vision, lethargy, depression, dysarthria and cerebral seizures; a malignant cardiac arrhythmia has been reported in one case.
Acute toxic psychoses in the form of states of confusion with visual hallucinations sometimes including coma and myoclonus have been observed after simultaneous administration of amantadine and other antiparkinsonian drugs.
b) Management of overdose
There is no known specific drug treatment or antidote. In the event of intoxication with film-coated tablets, vomiting should be induced and/or gastric lavage performed.
In the event of life-threatening intoxication, intensive care is necessary additionally. Therapeutic measures to be considered include fluid intake and acidification of the urine for more rapid excretion of the substance, and possibly sedation, anticonvulsive measures, and antiarrhythmic agents (lidocaine i.v.).
For the treatment of neurotoxic symptoms (such as those described above), intravenous administration of physostigmine can be tried in adults at a dose of 1-2 mg every 2 hours and in children 2  0.5 mg at intervals of 5-10 minutes up to a maximum dose of 2 mg.
Because of the low dialysability of amantadine (approx. 5%), haemodialysis is not an option.
It is advisable to monitor patients particularly closely for possible QT prolongation and for factors that promote the occurrence of torsade de pointes, e.g. electrolyte imbalances (particularly hypokalaemia and hypomagnesaemia) or bradycardia.

שימוש לפי פנקס קופ''ח כללית 1994 Influenza type A virus, parkinsonism (idiopathic & postencephalitic), drug induced extrapyramidal reactions, symptomatic parkinsonism caused by carbon monoxide intoxication or cerebral arteriosclerosis in the elderly
תאריך הכללה מקורי בסל 01/01/1995
הגבלות תרופה שאושרה לשימוש כללי בקופ'ח

בעל רישום

MEGAPHARM LTD

רישום

137 43 27100 00

מחיר

0 ₪

מידע נוסף

עלון מידע לרופא

10.06.14 - עלון לרופא

עלון מידע לצרכן

10.06.14 - עלון לצרכן 21.01.14 - החמרה לעלון

לתרופה במאגר משרד הבריאות

פק-מרץ טבליות

קישורים נוספים

RxList WebMD Drugs.com